1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Eosinophilic enteropathy: new trials by email Literature Review of Eosinophilic enteropathy trials Research Report on Eosinophilic enteropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sirolimus for Eosinophil-Associated Gastrointestinal Disorders sirolimus - Eosinophilic Gastroenteritis, Eosinophilic Esophagitis | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 4 | 2013-03-07 | 2018-07-05 |
| Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Mepolizumab - Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 24 | 2001-12-01 | 2020-07-29 |
Eosinophilic Esophagitis (2) · Churg-Strauss Syndrome (1) · Food Hypersensitivity (1) · Hypereosinophilic Syndrome (1)
Digestive System Diseases (2) · Eosinophilia (2) · Esophageal Diseases (2) · Esophagitis (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Leukocyte Disorders (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1)
Sirolimus (1) · mepolizumab (1)
Children's Hospital Medical Center, Cincinnati (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2)
Calman P Prussin, M.D. (1) · Marc E. Rothenberg, MD (1)